Login to Your Account

FDA Panel OKs Kynapid, But Votes Against Pulzium

By Donna Young

Thursday, December 13, 2007
A panel of federal advisers told the FDA that it should approve Kynapid but reject Pulzium to treat atrial fibrillation, a condition in which the two uppermost chambers of the heart beat irregularly and at an extremely rapid rate. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription